Physician profile
David J Tennent
NPI 1225303043
$9,728.90
in general payments reported to CMS, 2019-2025
8 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,186 · 2020: $1,657 · 2021: $1,521 · 2022: $1,434 · 2023: $314 · 2024: $102 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,252 · Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,251.81 |
| Food and Beverage | $679.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $4,323.09 | 2019-2024 | |
| Arthrex, INC. | $2,612.13 | 2019 | |
| Synthes Gmbh | $1,383.57 | 2025 | |
| Stryker Corporation | $1,129.51 | 2019-2025 | Axsos, Asnis, Variax |
| Vericel Corporation | $128.49 | 2021-2022 | |
| Mission Medical Distribution, LLC | $127.55 | 2024-2025 | |
| Bioventus LLC | $17.09 | 2025 | Durolane |
| Orthofix Medical, INC. | $7.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tennent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.